Radium-223 treatment outcomes in patients with metastatic castration-resistant prostate cancer: A Taiwan-Japan collaborative cohort study
Biomedical Journal
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Cite
Get new articles on “General Medicine”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Radium-223 treatment outcomes in patients with metastatic castration-resistant prostate cancer: A Taiwan-Japan collaborative cohort study. // Biomedical Journal. – URL: https://www.sciencedirect.com/science/article/pii/S2319417026000326?dgcid=rss_sd_all
Radium-223 treatment outcomes in patients with metastatic castration-resistant prostate cancer: A Taiwan-Japan collaborative cohort study. Biomedical Journal. https://www.sciencedirect.com/science/article/pii/S2319417026000326?dgcid=rss_sd_all
“Radium-223 treatment outcomes in patients with metastatic castration-resistant prostate cancer: A Taiwan-Japan collaborative cohort study.” Biomedical Journal.
@article{article37887,
title = {Radium-223 treatment outcomes in patients with metastatic castration-resistant prostate cancer: A Taiwan-Japan collaborative cohort study},
journal = {Biomedical Journal},
url = {https://www.sciencedirect.com/science/article/pii/S2319417026000326?dgcid=rss_sd_all}
}